Form 4 holding
Chief Medical Officer
Spero Therapeutics, Inc.
- Security class
- Common Stock
- Shares / value
- 62,081
- Estimated value
- $78,843
- Report date
- 01 Feb 2022
- Price
- $1.27
- Ownership
- Direct
David A. Melnick - Chief Medical Officer at Spero Therapeutics, Inc.
Issuer-level insider activity
- Role
- Chief Medical Officer
- Issuer ticker
- SPRO on Nasdaq
- Entity type
- Individual
- Source filing history
- Open source filing history
Identity
Names, identifiers, and filing context for this profile.
1 identity field
Source evidence
Original filing metadata and source links for verification.
1 source field
No buys or sells have been reported by David A. Melnick since 14 Oct 2025
Reported holdings for David A. Melnick in Spero Therapeutics, Inc.
Form 4 holding
Chief Medical Officer
Spero Therapeutics, Inc.
- Security class
- Stock Option (Right to Buy)
- Shares / value
- 53,190
- Estimated value
- $59,573
- Report date
- 01 Feb 2022
- Price
- $1.12
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
Transaction history for David A. Melnick in Spero Therapeutics, Inc.
| Sym | Class | Transaction | % | SEC-reported value | SEC-reported price | Shares | Shares after | Date | Ownership |
|---|
* marks a reported price that did not pass the local price check.